WallStreetZenWallStreetZen

NASDAQ: BTTX
Better Therapeutics Inc Stock Ownership - Who owns Better Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Better Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Andrew J. ArmaninoDirector2023-07-27274,010$0.73
$200.03kBuy
Mark A. BermanChief Medical Officer2023-07-2754,802$0.73
$40.01kBuy
Geoffrey M. ParkerDirector2023-07-27685,025$0.73
$500.07kBuy
Frank KarbeChief Executive Officer2023-07-27137,005$0.73
$100.01kBuy
Elder GrangerDirector2023-07-2734,251$0.73
$25.00kBuy
David P. PerryExecutive Chairman2023-07-271,233,045$0.73
$900.12kBuy
Elder GrangerDirector2023-05-16600$0.87
$520.20Buy
Andrew J. ArmaninoDirector2023-04-10303,030$0.83
$250.00kBuy
Frank KarbeChief Executive Officer President Treasurer and Secretary2023-04-10242,424$0.83
$200.00kBuy
Geoffrey M. ParkerDirector2023-04-10303,030$0.83
$250.00kBuy

1 of 2

BTTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BTTX insiders and whales buy or sell their stock.

BTTX Shareholders

What type of owners hold Better Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
David P. Perry67.89%27,546,794$9.37MInsider
Mauleffinch 2015 Trust Georgianna8.96%3,636,364$1.24MInsider
Kevin J. Appelbaum5.95%2,412,969$820.41kInsider
Mountain Crest Capital LLC3.39%1,374,000$467.16kInsider
Dong Liu3.39%1,374,000$467.16kInsider
Geoffrey M. Parker2.66%1,081,388$367.67kInsider
Andrew J. Armanino1.86%756,702$257.28kInsider
Vanguard Group Inc1.08%438,479$149.08kInstitution
Frank Karbe1.06%429,429$146.01kInsider
Mark A. Berman0.96%388,191$131.98kInsider

1 of 3

BTTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BTTX2.66%97.34%Net BuyingNet Buying
ELOX0.29%99.71%
SRZN31.56%68.44%Net Buying
GOVX0.62%99.38%Net BuyingNet Buying
FREQ13.18%16.71%Net SellingNet Selling
View Top Biotech Stocks

Better Therapeutics Stock Ownership FAQ

Who owns Better Therapeutics?

Better Therapeutics (NASDAQ: BTTX) is owned by 2.66% institutional shareholders, 97.54% Better Therapeutics insiders, and 0.00% retail investors. David P. Perry is the largest individual Better Therapeutics shareholder, owning 27.55M shares representing 67.89% of the company. David P. Perry's Better Therapeutics shares are currently valued at $9.37M.

If you're new to stock investing, here's how to buy Better Therapeutics stock.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.